Zobrazeno 1 - 10
of 1 195
pro vyhledávání: '"Citrate anticoagulation"'
Publikováno v:
Journal of Pediatric Critical Care, Vol 11, Iss 5, Pp 218-226 (2024)
Continuous renal replacement therapy (CRRT) in children is quite challenging to manage because of their increased propensity for circuit clotting. The anticoagulant strategies are paramount in reducing the downtime in pediatric CRRT. The most commonl
Externí odkaz:
https://doaj.org/article/c579250654a64e3d83f6d22ffba0c92c
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-7 (2024)
Abstract Background To explore the feasibility and effectiveness of a segmented sodium citrate solution anticoagulation strategy in patients receiving CRRT. Methods A prospective, randomized controlled study was conducted. Results According to the in
Externí odkaz:
https://doaj.org/article/8692d21c0dab4fc1b94a6e8e02ad1db6
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Regional citrate anticoagulation (RCA) is recommended during continuous renal replacement therapy. Compared to systemic anticoagulation, RCA provides a longer filter lifespan with the risk of metabolic alkalosis and impaired calci
Externí odkaz:
https://doaj.org/article/f84b1fd93cbb4b02916749a33c36d150
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract There remains no optimal anticoagulation protocol for continuous renal replacement therapy (CRRT) with regional citrate anticoagulation (RCA) in pediatric patients with elevated D-dimer levels. We aimed to assess the effects of different ant
Externí odkaz:
https://doaj.org/article/803e410fc5564eae90c3851b9d1a8c07
Publikováno v:
Renal Failure, Vol 46, Iss 2 (2024)
Introduction Regional citrate anticoagulation is a preferred option for renal replacement therapy in critically ill patients. However, current implementations ignore individual differences that may exist in the fluctuation of patients’ ionized calc
Externí odkaz:
https://doaj.org/article/63abbc450c5845acb04e616af33c6aaf
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-9 (2024)
Abstract Purpose The choice of continuous renal replacement therapy (CRRT) anticoagulation program for patients at high risk of bleeding has always been a complex problem in clinical practice. Clinical regimens include regional citrate anticoagulatio
Externí odkaz:
https://doaj.org/article/ac518dd8792044a1a074b65a1e9c2c85
Autor:
Edin Botan, Ayşen Durak, Emrah Gün, Anar Gurbanov, Burak Balaban, Fevzi Kahveci, Hasan Özen, Hacer Uçmak, Ali Genco Gençay, Tanıl Kendirli
Publikováno v:
Journal of Pediatric Emergency and Intensive Care Medicine, Vol 10, Iss 3, Pp 198-204 (2023)
Introduction:The choice of anticoagulation in continuous renal replacement therapy (CRRT) is very important for circuit life and bleeding complications. The primary outcome of our study was circuit lifespan. Secondary outcomes, we aimed to identify m
Externí odkaz:
https://doaj.org/article/58c25a8b280043c38a710e50da8723f2
Autor:
Rita Jacobs, Walter Verbrugghe, Jason Bouziotis, Ingrid Baar, Karolien Dams, Annick De Weerdt, Philippe G. Jorens
Publikováno v:
Life, Vol 14, Iss 10, p 1304 (2024)
(1) Background: Citrate is preferred in continuous renal replacement therapy (CRRT) for critically ill patients because it prolongs filter life and reduces bleeding risks compared to unfractionated heparin (UFH). However, regional citrate anticoagula
Externí odkaz:
https://doaj.org/article/1fc12f2f5e204f9dbb5efca210007a37
Autor:
Jorge Alberto Menegasso Vieira, Isabel Cristina Reinheimer, Amanda Corrêa dos Santos, Fernando Kowarick Halperin, Luiza Aguirre Susin, Lia Portella Staub, Raquel Jaqueline Eder Ribeiro, Julia Braga da Silveira, Lucas Friedrich Fontoura, Diego Candido de Souza, Karen Patrícia Nunes, Vandrea Carla de Souza, Luciano da Silva Selistre, Carlos Eduardo Poli-de-Figueiredo
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Background Prolonged hemodialysis (HD) is performed from 6 to 12 h and can last up to 24 h. To prevent system clotting some studies suggest that Regional Citrate Anticoagulation (RCA) use reduces bleeding rates relative to systemic heparin.
Externí odkaz:
https://doaj.org/article/187e2665e1b7403e835f1c5a6b442068
Publikováno v:
Linchuang shenzangbing zazhi, Vol 23, Iss 10, Pp 825-834 (2023)
Objective To compare adverse events (AEs) of regional citrate anticoagulation (RCA) versus heparin anticoagulation during continuous renal replacement therapy (CRRT) through systematic review and trial sequential analysis. Methods Based upon the rele
Externí odkaz:
https://doaj.org/article/0747a41565834380af506a2232fe0a37